跳至主要内容
临床试验/ACTRN12610000001099
ACTRN12610000001099已完成未知

Prospective, open label, randomised, cross-over clinical trial to evaluate the performance of Focus (registered trademark) 1-2 Week, Focus (registered trademark) Monthly and FreshLook(registered trademark) Handling Tint contact lenses on a daily wear, daily disposable wear schedule in neophyte and experienced East Asian wearers.

CIBA VISIO0 个研究点目标入组 40 人开始时间: 2010年1月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Be able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent;
  • -Be at least 18 years old;
  • -Be of East Asian ethnicity (either Japanese, Chinese, Taiwanese or Korean);
  • -Be willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
  • -Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses;
  • -Have vision correctable to at least 6/12 (20/40) or better in each eye with contact lenses;
  • -Be experienced or may be inexperienced at wearing contact lenses.
  • -Have a current spectacle correction.

排除标准

  • -Any pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses;
  • -Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosis. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants;
  • -An active corneal infection or any active ocular disease that would affect wearing of contact lenses;
  • -Use of or a need for concurrent category S3 and above ocular medication up to 12 weeks prior to and during the trial;
  • -Use of or a need for any systemic medication or topical medications or participation in any clinical trial which may alter normal ocular findings/are known to affect a participant’s ocular health/physiology or contact lens performance either in an adverse manner or risk providing a false positive.
  • N.B. Systemic antihistamines are allowed on an ‘as needed basis’, provided they are not used prophylactically during the trial;
  • -Eye surgery within 12 weeks immediately prior to enrolment for this trial;
  • -Previous corneal refractive surgery;
  • -Contraindications to contact lens wear;
  • -Contact lens wear within 1 calendar day of initial lens fitting (washout period to be performed post enrolment if necessary)
  • -Allergy or intolerance to topical anaesthetics

研究者

发起方
CIBA VISIO

相似试验